What is a stock summary page? Click here for an overview.
Business Description
Biomind Labs Inc
NAICS : 541714
SIC : 3741
ISIN : CA0907021012
Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -28.64 | |||||
| Debt-to-Equity | -0.58 | |||||
| Debt-to-EBITDA | -2.8 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.73 | |||||
| 14-Day RSI | 97.94 | |||||
| 3-1 Month Momentum % | 127.57 | |||||
| 6-1 Month Momentum % | 40 | |||||
| 12-1 Month Momentum % | 536.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.56 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -848.13 | |||||
| ROIC % | -38.46 | |||||
| ROC (Joel Greenblatt) % | -1217.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -79.33 | |||||
| EV-to-EBITDA | -81 | |||||
| EV-to-FCF | -55.61 | |||||
| Earnings Yield (Greenblatt) % | -1.26 | |||||
| FCF Yield % | -1.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BMNDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomind Labs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.014 | ||
| Beta | -0.05 | ||
| 3-Year Sharpe Ratio | 0.72 | ||
| 3-Year Sortino Ratio | 1.69 | ||
| Volatility % | 181.03 | ||
| 14-Day RSI | 97.94 | ||
| 14-Day ATR ($) | 0.000578 | ||
| 20-Day SMA ($) | 0.7 | ||
| 12-1 Month Momentum % | 536.36 | ||
| 52-Week Range ($) | 0.089 - 0.7 | ||
| Shares Outstanding (Mil) | 77.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomind Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomind Labs Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomind Labs Inc Frequently Asked Questions
What is Biomind Labs Inc(BMNDF)'s stock price today?
The current price of BMNDF is $0.70. The 52 week high of BMNDF is $0.70 and 52 week low is $0.09.
When is next earnings date of Biomind Labs Inc(BMNDF)?
The next earnings date of Biomind Labs Inc(BMNDF) is .
Does Biomind Labs Inc(BMNDF) pay dividends? If so, how much?
Biomind Labs Inc(BMNDF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers